Novel agent abelacimab has potential to be a safer anticoagulant, according to the randomized AZALEA-TIMI 71 trial. The trial had been stopped early because of a surprisingly large reduction in bleeds ...
Eagle Pharmaceuticals has issued a voluntary recall of four lots of Argatroban Injection 50mg/50mL (1mg/1mL), an anticoagulant due to visible particulate.The affected lots may cause embolization or ...
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial, with one of the candidates also matching Bristol Myers Squibb and Pfizer’s ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Bivalirudin for Injection in the ...
NEW YORK, June 7, 2017 /PRNewswire/ -- Ken Research announced its latest publication on "Global Anticoagulants Market Outlook to 2020 – Demand for Patented NOACs with Prevalence of Cardiac Diseases to ...
Anticoagulant or antiplatelet drugs, sometimes called blood thinners, help prevent blood clots. There are many options, including heparin and warfarin. Preventing clots reduces the risk of stroke and ...
The oral anticoagulant drug apixaban may offer a safer, more effective alternative to standard home heparin injections for patients taking extended prophylaxis (EP) to prevent blood-clot-related ...
The US Food and Drug Administration (FDA) has approved dabigatran etexilate (Pradaxa) oral pellets for the treatment of venous thromboembolism (VTE) in children aged 3 months to less than 12 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback